Want to see IN:UNIENTER full AI Analyst Report?
Top Page
Uniphos Enterprises Limited
(UNIENTER)
Select Model
Select Model
Rating:49Neutral
Price Target:
₹85.00
▼(-41.52% Downside)
Action:Reiterated
Date:10/27/26
The score is held back primarily by weak and inconsistent operating profitability (negative EBIT across the period), sharp revenue volatility, and choppy cash-flow support for earnings. Offsetting this, the company’s debt-free balance sheet meaningfully reduces financial risk, and the dividend yield provides some valuation support, but technicals remain bearish with price below key moving averages and negative MACD.
Positive Factors
Debt-free balance sheet
A debt-free balance sheet materially lowers financial risk by avoiding mandatory interest and principal payments. This gives Uniphos greater flexibility to withstand weak trading conditions, preserve liquidity, and potentially fund working-capital needs without relying on external borrowing.
Negative Factors
Sharp revenue contraction
A sharp recent revenue contraction, combined with earlier volatility, weakens visibility into demand and makes future earnings harder to plan. For a chemical trading business, unstable sales can reduce purchasing leverage, impair fixed-cost absorption, and limit the predictability of cash generation.
Read all positive and negative factors
Positive Factors
Negative Factors
Debt-free balance sheet
A debt-free balance sheet materially lowers financial risk by avoiding mandatory interest and principal payments. This gives Uniphos greater flexibility to withstand weak trading conditions, preserve liquidity, and potentially fund working-capital needs without relying on external borrowing.
Read all positive factors
Uniphos Enterprises Limited (UNIENTER) vs. iShares MSCI India ETF (INDA)
Market Cap
₹5.91B
Dividend Yield4.1%
Average Volume (3M)621.00
Price to Earnings (P/E)29.3
Beta (1Y)1.09
Revenue Growth-77.13%
EPS GrowthN/A
CountryIN
Employees2,022
SectorGeneral
Sector StrengthN/A
IndustryChemicals
Share Statistics
EPS (TTM)2.91
Shares Outstanding69,545,845
10 Day Avg. Volume592
30 Day Avg. Volume621
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.26
Price to Sales (P/S)19.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Uniphos Enterprises Limited Business Overview & Revenue Model
Company Description
Uniphos Enterprises Limited, primarily operating in India, is involved in the trade of chemical products and various other goods. It also makes investments in both publicly listed and unlisted securities. The company was founded in 1969 and has it...
How the Company Makes Money
UNIENTER primarily makes money through the sale of chemicals sourced from manufacturers and sold onward to customers, earning revenue from the invoiced value of goods sold. Its core revenue model is therefore trading/distribution: the company buys...
Uniphos Enterprises Limited Financial Statement Overview
Summary
Income Statement
36
Negative
Balance Sheet
78
Positive
Cash Flow
41
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 263.09M | 320.03M | 1.12B | 506.48M | 14.72M | 12.22M |
| Gross Profit | -4.64M | -18.27M | 8.02M | 652.00K | 164.00K | -11.00K |
| EBITDA | 210.40M | 215.10M | 22.99M | -30.90M | -28.63M | -31.26M |
| Net Income | 202.57M | 207.11M | 2.78M | 386.14M | 392.25M | 546.04M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 26.19B | 28.42B | 20.78B | 30.95B | 33.02B |
| Cash, Cash Equivalents and Short-Term Investments | 203.54M | 209.51M | 162.37M | 469.95M | 517.30M | 391.46M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | -24.47B | 1.72B | 1.00B | 20.50M | 978.68M | 1.21B |
| Stockholders Equity | 24.47B | 24.47B | 27.42B | 20.75B | 29.98B | 31.81B |
Cash Flow | ||||||
| Free Cash Flow | -20.75M | 0.00 | -27.17M | -34.67M | -14.66M | 5.20M |
| Operating Cash Flow | -20.75M | 213.92M | -27.17M | -34.67M | -14.66M | 5.20M |
| Investing Cash Flow | 65.05M | -148.99M | 527.70M | 501.62M | 406.29M | 204.34M |
| Financing Cash Flow | -34.77M | -34.77M | -409.58M | -452.05M | -392.93M | -236.46M |
Uniphos Enterprises Limited Technical Analysis
Negative
145.35
Price Trends
90.27
Negative
95.84
Negative
101.71
Negative
Market Momentum
-1.62
Negative
44.77
Neutral
50.01
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:UNIENTER, the sentiment is Negative. The current price of 145.35 is above the 20-day moving average (MA) of 85.95, above the 50-day MA of 90.27, and above the 200-day MA of 101.71, indicating a bearish trend. The MACD of -1.62 indicates Negative momentum. The RSI at 44.77 is Neutral, neither overbought nor oversold. The STOCH value of 50.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:UNIENTER.
Uniphos Enterprises Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | ₹7.87B | 20.54 | ― | 0.35% | -12.40% | -3.04% | |
62 Neutral | ₹11.80B | 18.09 | ― | 0.31% | 8.15% | 41.80% | |
62 Neutral | ₹7.35B | 18.38 | ― | 0.84% | 49.58% | 43.22% | |
62 Neutral | ₹9.03B | 11.22 | ― | 0.40% | 13.23% | 22.22% | |
57 Neutral | ₹12.20B | 22.57 | ― | 0.99% | 1.41% | 946.41% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
49 Neutral | ₹5.91B | 29.29 | ― | 4.10% | -77.13% | ― |
* General Sector Average
IN:UNIENTER
Uniphos Enterprises Limited
85.01
-61.09
-41.81%
IN:AMNPLST
Amines & Plasticizers Ltd.
143.10
-79.28
-35.65%
IN:DMCC
DMCC Speciality Chemicals Limited
294.90
-5.46
-1.82%
IN:INDOAMIN
Indo Amines Limited
124.45
-7.02
-5.34%
IN:PUNJABCHEM
Punjab Chemicals & Crop Protection Ltd.
962.65
-503.91
-34.36%
IN:VALIANTORG
Valiant Organics Limited
435.30
128.40
41.84%
Uniphos Enterprises Limited Corporate Events
Uniphos Enterprises Reports Q1 FY27 Unaudited Loss Amid Volatile Comprehensive Income
Aug 14, 2026
Uniphos Enterprises Limited, an exchange-listed Indian company headquartered in Gujarat with corporate offices in Mumbai, reported its unaudited financial results for the quarter ended June 30, 2026. The firm’s equity is traded on BSE and NS...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.